NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquarter in Kloten, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
3
Frequently Asked Questions
What is Market Cap of NewcelX Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. NewcelX Ltd. market cap is $13.13M.
What is the 52-week high for NewcelX Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NewcelX Ltd. 52 week high is $30.80 as of March 03, 2026.
What is the 52-week low for NewcelX Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NewcelX Ltd. 52 week low is $1.89 as of March 03, 2026.
What is NewcelX Ltd. stock price today?
NewcelX Ltd. stock price today is $2.82.
What was NewcelX Ltd. stock price yesterday?
NewcelX Ltd. stock price yesterday was $2.83.
What is the PE ratio of NewcelX Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. NewcelX Ltd.'s P/E ratio is -0.16.
What is the Price-to-Book ratio of NewcelX Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. NewcelX Ltd. P/B ratio is 0.4169.
What is the 50-day moving average of NewcelX Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. NewcelX Ltd. 50-day moving average is $2.58.
